Oral Dissolving Sebetralstat Eases HAE Attacks in Young Children
An innovative orally disintegrating tablet version of sebetralstat, marketed as Ekterly, has demonstrated promising outcomes for treating hereditary angioedema (HAE) in young children, mirroring the effectiveness observed with the standard tablet formulation in adults, according to findings from a phase…